The financing has been subscribed by a strong group of investors that include the existing investors T-bolaget AB, Wikow Ventures AB & Servisen Holding AB as well as existing private shareholders but also new financial investors such as the SGP Group (Svenska Garantiprodukter AB).
The funds will be used to further develop the company’s product line and research activities, and to expand its sales and marketing activities.
Olof Sköld, CEO at Denator says: “We are pleased to have secured this sizeable financing round. The strong level of commitment from our shareholders will enable the company to continue its expansion. This financing round underlines the significant commercial opportunity the company has through applying its stabilization technology to several fields within the Life Science market. Our technology represents a significant advance over other approaches and this funding will support the next step in the company's development."
Henrik Wingstrand, CEO of T-bolaget AB says: ”Denator is a core holding for us and we are happy to continue to support this very promising company.”
